FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308685723> ?p ?o ?g. }

• W4308685723 endingPage "73" @default.
• W4308685723 startingPage "73" @default.
• W4308685723 abstract "Importance Irreversible vision loss from primary open-angle glaucoma (POAG) can be prevented through timely diagnosis and treatment, although definitive diagnosis can be difficult in early-stage disease. As a consequence, large numbers of individuals with suspected glaucoma require regular monitoring, even though many of these may never develop disease and other high-risk individuals with suspected glaucoma may have delayed or inadequate treatment. POAG is one of the most heritable common diseases, and this provides an opportunity to use genetic instruments in risk-stratified screening, diagnosis, and treatment of early glaucoma. Objective To assess the association of glaucoma polygenic risk with glaucoma progression in early-stage disease. Design, Setting, and Participants This cohort study used clinical and genetic data obtained from a longitudinal cohort study, Progression Risk of Glaucoma: Relevant SNPs With Significant Association (PROGRESSA). Participants of European ancestry with characteristic optic nerve head changes suggestive of glaucoma were included. Data were collected between February 2012 and June 2020. Analysis took place between July 2020 and April 2022. Main Outcomes and Measures The association of a glaucoma polygenic risk score (PRS) (2673 uncorrelated variants) with rate of peripapillary retinal nerve fiber layer thinning on optical coherence tomography and progression of visual field loss on 24-2 Humphrey visual fields. Results A total of 1777 eyes from 896 individuals had sufficient data for structural progression analyses and 1563 eyes from 808 individuals for functional progression analyses. The mean (SD) age was 62.1 (9.9) years, 488 (44%) were male, and 1087 of 1103 individuals (98.5%) had European ancestry. An ancestrally matched normative population cohort (n = 17 642) was used for PRS reference. Individuals in the top 5% PRS risk group were at a higher risk of visual field progression compared with the remaining 95% after 5 years (hazard ratio, 1.5; 95% CI, 1.13-1.97; P = .005). Conversely, those in the bottom 20% PRS risk group were at a lower risk of visual field progression compared with an intermediate risk group over 3 years (hazard ratio, 0.52; 95% CI, 0.28-0.96; P = .04). Conclusions and Relevance In this study, high polygenic risk was associated with more rapid structural and functional progression in early POAG, despite more intensive treatment. A PRS may serve as a valuable adjunct to identify individuals who stand to benefit the most from more frequent surveillance and earlier or more intensive treatment." @default.
• W4308685723 created "2022-11-14" @default.
• W4308685723 creator A5005522131 @default.
• W4308685723 creator A5010178491 @default.
• W4308685723 creator A5012599011 @default.
• W4308685723 creator A5027915808 @default.
• W4308685723 creator A5029948119 @default.
• W4308685723 creator A5037433676 @default.
• W4308685723 creator A5037639355 @default.
• W4308685723 creator A5039731589 @default.
• W4308685723 creator A5040284130 @default.
• W4308685723 creator A5041104671 @default.
• W4308685723 creator A5046117391 @default.
• W4308685723 creator A5047701250 @default.
• W4308685723 creator A5062605162 @default.
• W4308685723 creator A5078949408 @default.
• W4308685723 creator A5086317817 @default.
• W4308685723 creator A5091199638 @default.
• W4308685723 date "2023-01-01" @default.
• W4308685723 modified "2023-09-30" @default.
• W4308685723 title "Association of High Polygenic Risk With Visual Field Worsening Despite Treatment in Early Primary Open-Angle Glaucoma" @default.
• W4308685723 cites W2130206051 @default.
• W4308685723 cites W2147333897 @default.
• W4308685723 cites W2297621929 @default.
• W4308685723 cites W2759151194 @default.
• W4308685723 cites W2969585998 @default.
• W4308685723 cites W2973872386 @default.
• W4308685723 cites W3000547714 @default.
• W4308685723 cites W3000726199 @default.
• W4308685723 cites W3110871091 @default.
• W4308685723 cites W3162929004 @default.
• W4308685723 cites W3178280850 @default.
• W4308685723 doi "https://doi.org/10.1001/jamaophthalmol.2022.4688" @default.
• W4308685723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36355370" @default.
• W4308685723 hasPublicationYear "2023" @default.
• W4308685723 type Work @default.
• W4308685723 citedByCount "7" @default.
• W4308685723 countsByYear W43086857232022 @default.
• W4308685723 countsByYear W43086857232023 @default.
• W4308685723 crossrefType "journal-article" @default.
• W4308685723 hasAuthorship W4308685723A5005522131 @default.
• W4308685723 hasAuthorship W4308685723A5010178491 @default.
• W4308685723 hasAuthorship W4308685723A5012599011 @default.
• W4308685723 hasAuthorship W4308685723A5027915808 @default.
• W4308685723 hasAuthorship W4308685723A5029948119 @default.
• W4308685723 hasAuthorship W4308685723A5037433676 @default.
• W4308685723 hasAuthorship W4308685723A5037639355 @default.
• W4308685723 hasAuthorship W4308685723A5039731589 @default.
• W4308685723 hasAuthorship W4308685723A5040284130 @default.
• W4308685723 hasAuthorship W4308685723A5041104671 @default.
• W4308685723 hasAuthorship W4308685723A5046117391 @default.
• W4308685723 hasAuthorship W4308685723A5047701250 @default.
• W4308685723 hasAuthorship W4308685723A5062605162 @default.
• W4308685723 hasAuthorship W4308685723A5078949408 @default.
• W4308685723 hasAuthorship W4308685723A5086317817 @default.
• W4308685723 hasAuthorship W4308685723A5091199638 @default.
• W4308685723 hasConcept C118487528 @default.
• W4308685723 hasConcept C126322002 @default.
• W4308685723 hasConcept C201903717 @default.
• W4308685723 hasConcept C2776058522 @default.
• W4308685723 hasConcept C2776521421 @default.
• W4308685723 hasConcept C2778527774 @default.
• W4308685723 hasConcept C2780592520 @default.
• W4308685723 hasConcept C2780837183 @default.
• W4308685723 hasConcept C2991803831 @default.
• W4308685723 hasConcept C71924100 @default.
• W4308685723 hasConcept C72563966 @default.
• W4308685723 hasConceptScore W4308685723C118487528 @default.
• W4308685723 hasConceptScore W4308685723C126322002 @default.
• W4308685723 hasConceptScore W4308685723C201903717 @default.
• W4308685723 hasConceptScore W4308685723C2776058522 @default.
• W4308685723 hasConceptScore W4308685723C2776521421 @default.
• W4308685723 hasConceptScore W4308685723C2778527774 @default.
• W4308685723 hasConceptScore W4308685723C2780592520 @default.
• W4308685723 hasConceptScore W4308685723C2780837183 @default.
• W4308685723 hasConceptScore W4308685723C2991803831 @default.
• W4308685723 hasConceptScore W4308685723C71924100 @default.
• W4308685723 hasConceptScore W4308685723C72563966 @default.
• W4308685723 hasIssue "1" @default.
• W4308685723 hasLocation W43086857231 @default.
• W4308685723 hasLocation W43086857232 @default.
• W4308685723 hasOpenAccess W4308685723 @default.
• W4308685723 hasPrimaryLocation W43086857231 @default.
• W4308685723 hasRelatedWork W2017696393 @default.
• W4308685723 hasRelatedWork W275622479 @default.
• W4308685723 hasRelatedWork W2908921822 @default.
• W4308685723 hasRelatedWork W2910969643 @default.
• W4308685723 hasRelatedWork W2950343339 @default.
• W4308685723 hasRelatedWork W2972928644 @default.
• W4308685723 hasRelatedWork W2998066012 @default.
• W4308685723 hasRelatedWork W3037342716 @default.
• W4308685723 hasRelatedWork W3153753501 @default.
• W4308685723 hasRelatedWork W4225282422 @default.
• W4308685723 hasVolume "141" @default.
• W4308685723 isParatext "false" @default.
• W4308685723 isRetracted "false" @default.
• W4308685723 workType "article" @default.